Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: Crest Nicholson CEO makes £0.2m investment
(Sharecast News) - Crest Nicholson was in the red in late trading on Tuesday, after its chief executive officer bought almost £0.2m worth of shares. The FTSE 250 housebuilder said Peter Truscott purchased 85,000 shares in an open market transaction in London on Monday.
Truscott paid 228.48p for each share, spending a total of £194,208 on his investment.
At 1542 BST, shares in Crest Nicholson Holdings were down 2.01% at 224.6p.
Reporting by Josh White at Sharecast.com.
Top Director Buys
Symphony International Holdings Ltd. (SIHL) Director name: Thadani,Anil Amount purchased: 461,384 @ $0.48 Value: $221,464.32
Crest Nicholson Holdings (CRST) Director name: Truscott ,Peter Amount purchased: 85,000 @ 228.48p Value: £194,208.00
Civitas Social Housing (CSH) Director name: Wrobel,Michael Amount purchased: 79,402 @ 75.04p Value: £59,584.93
Jupiter Fund Management (JUP) Director name: Neubert,Suzy Amount purchased: 46,000 @ 107.74p Value: £49,560.40
(HWG) Director name: Shillaw,Lynda Amount purchased: 14,102 @ 141.82p Value: £19,999.46
Cranswick (CWK) Director name: Bottomley,Mark Amount purchased: 639 @ 3,127.26p Value: £19,983.19
Cranswick (CWK) Director name: Bottomley,Mark Amount purchased: 641 @ 3,115.49p Value: £19,970.29
(HWG) Director name: Bromfield ,Angela Amount purchased: 14,072 @ 141.31p Value: £19,885.14
Speedy Hire (SDY) Director name: Dasani,Shatish D. Amount purchased: 40,000 @ 40.00p Value: £16,001.16
Audioboom Group (BOOM) Director name: Tobin,Michael Amount purchased: 1,886 @ 500.00p Value: £9,430.00
Bivictrix Therapeutics (BVX) Director name: Ross,Iain Gladstone Amount purchased: 50,000 @ 17.70p Value: £8,850.00
Ms International (MSI) Director name: Bell,Nicholas Amount purchased: 2,500 @ 330.00p Value: £8,250.00
Bivictrix Therapeutics (BVX) Director name: Ross,Iain Gladstone Amount purchased: 30,000 @ 17.80p Value: £5,340.00
Bivictrix Therapeutics (BVX) Director name: Ross,Iain Gladstone Amount purchased: 25,000 @ 17.90p Value: £4,475.00
Fdm Group (holdings) (FDM) Director name: McLaren ,Michael (Mike) Amount purchased: 67 @ 743.00p Value: £497.81
Bp (BP.) Director name: Auchincloss,Murray Amount purchased: 82 @ 450.80p Value: £369.66
Bp (BP.) Director name: Looney,Bernard Amount purchased: 70 @ 450.80p Value: £315.56
Schroders (SDR) Director name: Harrison ,Peter Amount purchased: 8 @ 2,708.97p Value: £216.72
Schroders (SDR) Director name: Keers,Richard Amount purchased: 8 @ 2,708.97p Value: £216.72
Croda International (CRDA) Director name: Foots,Steve Amount purchased: 3 @ 6,964.00p Value: £208.92
Oxford Instruments (OXIG) Director name: Hill,Gavin Amount purchased: 7 @ 2,164.00p Value: £151.48
Oxford Instruments (OXIG) Director name: Barkshire,Ian Amount purchased: 7 @ 2,164.00p Value: £151.48
Zotefoams (ZTF) Director name: McGrath ,Gary Amount purchased: 53 @ 283.00p Value: £149.99
Sthree (STEM) Director name: Beach,Andrew Amount purchased: 40 @ 372.34p Value: £148.93
Zotefoams (ZTF) Director name: Stirling,David Amount purchased: 52 @ 283.00p Value: £147.16
Travis Perkins (TPK) Director name: Roberts,Nick Amount purchased: 17 @ 851.81p Value: £144.81
Croda International (CRDA) Director name: Maiden,Jez K Amount purchased: 2 @ 6,964.00p Value: £139.28
Gsk (GSK) Director name: Walmsley,Emma Amount purchased: 9 @ 1,362.09p Value: £122.59
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
